Open AccessTumor Regression After Treatment With Lenvatinib in FGFR2-Mutated Ameloblastoma
Author(s) -
Alice N. Weaver,
Frantz Francisque,
Daniel W. Bowles
Publication year - 2020
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
ISSN - 2473-4284
DOI - 10.1200/po.20.00175
Subject(s) - ameloblastoma , lenvatinib , oncology , cancer research , medicine , biology , cancer , dentistry , maxilla , thyroid cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom